Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization: an Open-label Randomized Controlled Trial

NCT06990685 is registered in ClinicalTrials.gov with The Second Hospital of Shandong University as lead sponsor.

NCT NCT06990685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06990685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization: an Open-label Randomized Controlled Trial
Lead sponsor
The Second Hospital of Shandong University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
December 31, 2027
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

assisted reproductive technology, in vitro fertilization, randomized controlled trial, salidroside